EPB148 Advanced HIV infection in the US: immune response to ART initiationE-posterART in acute, first- and second-line therapies
EPB147 Treatment experience of single-tablet dolutegravir/lamivudine in the United States: results from the 'real-world outcomes with dolutegravir-based two-drug-regimens for the treatment of HIV-1' (TANDEM study)E-posterART in acute, first- and second-line therapies
EPB146 Cost-effective continuous flow synthesis of HIV second and third generation integrase inhibitor drugs: a step towards local API manufacturing in AfricaE-posterART in acute, first- and second-line therapies
EPB145 Prevalence and Associated Factors of Healthy Aging with HIV in Latin AmericaE-posterOther issues related to aging with HIV
EPB144 Association of age at ART initiation with CD4:CD8 ratio recovery among virally suppressed people living with HIV, 2001-2019E-posterOther issues related to aging with HIV
EPB143 Comparative prevalence of mild cognitive impairment and Alzheimer's dementia in adult Ugandans living with HIV and demographically matched HIV-negative controlsE-posterOther issues related to aging with HIV
EPB142 Randomness of motor activity and cognitive performance in people living with HIV infectionE-posterOther issues related to aging with HIV
EPB141 Assessing sexual satisfaction amongst midlife women living with HIV in CanadaE-posterOther issues related to aging with HIV
EPB140 Improvements in patient-reported outcomes in older adults aged '¥50 years with HIV-1 after switching to a 2-drug regimen of fixed-dose combination DTG/3TC: 48-Week results From the SALSA studyE-posterOther issues related to aging with HIV
EPB139 Physical activity can reduce adiposity in older adults with HIV in the modern HIV eraE-posterOther issues related to aging with HIV
2251 - 2260 of 2485 items